Lv3
270 积分 2023-05-12 加入
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant Rejection
2个月前
已完结
Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA–Incompatible Kidney Transplantation
2个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
2个月前
已完结
Leveraging pharmacovigilance data to predict population-scale toxicity profiles of checkpoint inhibitor immunotherapy
7个月前
已完结
Deep contrastive learning enables genome-wide virtual screening
7个月前
已完结
Clinical Pharmacogenetic Model to Predict Response of MTX Monotherapy in Patients with Established Rheumatoid Arthritis After DMARD Failure
7个月前
已关闭
Patterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis
7个月前
已关闭
Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records
7个月前
已关闭
Predictors of Treatment Change Among Patients with Rheumatoid Arthritis Treated with TNF Inhibitors as First-Line Biologic Agent in the USA: A Cohort Study from Longitudinal Electronic Health Records
7个月前
已关闭
Genetic and clinical prediction models for the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a multicenter cohort study
7个月前
已完结
皖公网安备34019202002308
